{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/palliative-cancer-care-pain/management/managing-intracranial-pressure-pain/","result":{"pageContext":{"chapter":{"id":"ffae5598-ad34-57a7-bb50-018dcb5f63c8","slug":"managing-intracranial-pressure-pain","fullItemName":"Scenario: Managing intracranial pressure pain","depth":2,"htmlHeader":"<!-- begin field 2bf3f7f8-3f1b-4849-a3e9-d8e17ef4cc87 --><h2>Scenario: Managing intracranial pressure pain</h2><!-- end field 2bf3f7f8-3f1b-4849-a3e9-d8e17ef4cc87 -->","summary":"Covers the management of pain caused by increased intracranial pressure.","htmlStringContent":"<!-- begin item 2bd08cd3-ad50-4900-a2cb-a1c67206b9c0 --><!-- begin field be49a465-eb5f-4422-becf-acbd0086a0d8 --><p>From age 16 years onwards.</p><!-- end field be49a465-eb5f-4422-becf-acbd0086a0d8 --><!-- end item 2bd08cd3-ad50-4900-a2cb-a1c67206b9c0 -->","topic":{"id":"bc60f031-53af-530c-93e6-59feeef85bcb","topicId":"305b6c55-5a1b-4817-87a1-c88490ac688b","topicName":"Palliative cancer care - pain","slug":"palliative-cancer-care-pain","lastRevised":"Last revised in September 2020","chapters":[{"id":"edd133a3-7ad6-5893-82e6-230eb9313dd3","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"6c915659-224b-530e-9fb3-c0b95720d118","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"362828da-ca6f-5900-8441-afd9ea44af5b","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"cd526925-546a-5aac-93eb-485967fb5fd7","slug":"changes","fullItemName":"Changes"},{"id":"42928747-95fa-57d3-ae9e-7e3a6cf476a5","slug":"update","fullItemName":"Update"}]},{"id":"30edbf0f-7363-5f35-8126-77659a917fa3","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"21b41383-eea4-5b71-8b34-687f05a65a5d","slug":"goals","fullItemName":"Goals"},{"id":"6ae0a52d-6ca2-5d97-8aa0-2beccf699f7e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"d2aefa77-c551-539d-be41-67260cbe43ac","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7bc8c749-a90c-532b-854e-5ee96116de81","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"cf494151-3dcb-5990-851a-dd1cd70fab0c","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"9b0ea843-6c18-543c-b4f3-cbf22a737e5a","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"1078edd0-49b8-514b-aa1f-462d95bcb62c","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"203a281c-b6df-5d53-a704-aae8df1662a6","slug":"definition","fullItemName":"Definition"},{"id":"7842468e-5e33-52dc-ade6-5149de1e1436","slug":"origins-of-pain","fullItemName":"Origins of pain"},{"id":"cc8e90f5-0cd6-54d0-9bec-75e0729d34b2","slug":"prevalence","fullItemName":"Prevalence"}]},{"id":"288e99e9-418d-5e10-8b3b-94d111f68f63","fullItemName":"Management","slug":"management","subChapters":[{"id":"377406aa-05e6-5559-9f6e-4404453e407c","slug":"acute-severe-pain","fullItemName":"Scenario: Acute severe pain"},{"id":"3bc406e3-6db0-5386-a1a1-94f551e50a8d","slug":"assessment-of-pain","fullItemName":"Scenario: Assessment of pain"},{"id":"bfa2c711-266a-5133-a082-0655b9243bb5","slug":"managing-pain-non-emergency","fullItemName":"Scenario: Managing pain - non-emergency"},{"id":"fe447a1c-0019-5592-92ea-3d018c455b3b","slug":"managing-neuropathic-pain","fullItemName":"Scenario: Managing neuropathic pain"},{"id":"ffae5598-ad34-57a7-bb50-018dcb5f63c8","slug":"managing-intracranial-pressure-pain","fullItemName":"Scenario: Managing intracranial pressure pain"},{"id":"43317aee-6f8f-5d85-afed-94ec4c221bc5","slug":"managing-colic","fullItemName":"Scenario: Managing colic"},{"id":"4f3f67af-bf6a-5f02-84e4-c48ecc292167","slug":"managing-bone-pain","fullItemName":"Scenario: Managing bone pain"},{"id":"5c6257ce-9559-5775-a6e4-13eceaacff04","slug":"managing-muscle-spasm-pain","fullItemName":"Scenario: Managing muscle spasm pain"},{"id":"dba15959-96fa-5968-81ac-b3eb2b17604e","slug":"spinal-cord-compression","fullItemName":"Scenario: Spinal cord compression"},{"id":"d4083f8f-2904-55e8-9cb5-b20f6fcf10d2","slug":"end-of-life-care","fullItemName":"Scenario: End of life care"}]},{"id":"32fe1b7d-4328-56b2-9102-e26bc06c421d","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"6452b6ef-626b-552e-bf5c-0c21daf91352","slug":"nsaids","fullItemName":"NSAIDs"},{"id":"2ca1fa6a-d245-53df-a4e5-79f63db752f1","slug":"codeine-dihydrocodeine-tramadol","fullItemName":"Codeine, dihydrocodeine and tramadol"},{"id":"9d55dc66-3dff-524e-9ed1-7919aeca221b","slug":"strong-opioids","fullItemName":"Strong opioids"},{"id":"47ef042e-05dc-576a-81b5-e9d12888c2e8","slug":"tricyclic-antidepressants","fullItemName":"Tricyclic antidepressants"},{"id":"e39f9314-9fbb-5007-a7cf-c5ac3776546b","slug":"pregabalin","fullItemName":"Pregabalin"},{"id":"25156d8c-bb99-5e69-bf39-538e1a2c0265","slug":"gabapentin","fullItemName":"Gabapentin"},{"id":"58fbb7ca-b553-553e-8038-39021cfa2440","slug":"dexamethasone","fullItemName":"Dexamethasone"},{"id":"2e657be1-22f8-5617-85b0-b0d657de037e","slug":"diazepam","fullItemName":"Diazepam"},{"id":"d07c8c77-b362-533f-8d19-5397cdb2c2a6","slug":"baclofen","fullItemName":"Baclofen"},{"id":"e56de34b-8fb3-5a88-88fd-52f21822c95e","slug":"hyoscine-butylbromide","fullItemName":"Hyoscine butylbromide"}]},{"id":"ba95315f-c704-52b3-8e69-b66132db1afc","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[{"id":"36e5ad13-c74b-5b5b-a91a-dc99c76fe16c","slug":"drugs-to-treat-neuropathic-pain","fullItemName":"Drugs to treat neuropathic pain"}]},{"id":"e0efe998-f4e8-511b-9d28-24afd40c557e","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"de1ea0e8-6fc9-51d7-85ca-027ba77b3439","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"db05b928-3724-5155-8572-4a5741697b59","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"ad310ea3-10a0-5123-a3cb-4623f775c2a6","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"ae075009-b5ea-57cb-9dab-2d35fa7facb1","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"103ff2fc-2fa3-5785-a596-c4145bf1037f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"445d177d-22b8-5eef-aeaf-b7b0ae34c259","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"288e99e9-418d-5e10-8b3b-94d111f68f63","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"568e29d9-38b2-595c-ae09-46a8c5c8fb24","slug":"raised-intracranial-pressure","fullItemName":"Raised intracranial pressure","depth":3,"htmlHeader":"<!-- begin field f419eeb3-e7f7-4c7a-be63-eb6ee61aeba1 --><h3>How should I manage pain from raised intracranial pressure?</h3><!-- end field f419eeb3-e7f7-4c7a-be63-eb6ee61aeba1 -->","summary":null,"htmlStringContent":"<!-- begin item 3b85f1bf-ea07-4e89-a111-fac941dedf7b --><!-- begin field cfdb996e-2d99-478c-9352-73d323d5ede4 --><ul><li><strong>Consider whether a treatable underlying cause is present.</strong></li><li><strong>Discuss with an oncologist regarding the need for radiotherapy.</strong></li><li><strong>Use standard analgesics in a stepwise approach. </strong>For more information, see <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-cancer-care-pain/management/managing-pain-non-emergency/\">Scenario: Managing pain - non-emergency</a>.</li><li><strong>Also consider a trial of <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-cancer-care-pain/prescribing-information/dexamethasone/\">dexamethasone</a></strong> at a dose of 8–16 mg daily (taken in the morning), titrated down to the lowest dose that controls symptoms:<ul><li>If the volume of tablets or injection is difficult to manage in a single dose, it is acceptable to split the dose, in which case it should be given at 8am and 12pm (noon).</li><li>Have a low threshold for considering gastroprotection with a proton pump inhibitor.</li><li>Response to dexamethasone should be assessed after 5–7 days, but extensive cerebral oedema may take 2–3 weeks to resolve.</li><li>If there has been no response, discontinue dexamethasone immediately.</li><li>If there has been a benefit, review frequently and reduce to the lowest dose that controls symptoms (for example, reduce by 2 mg every fifth day).</li></ul></li></ul><!-- end field cfdb996e-2d99-478c-9352-73d323d5ede4 --><!-- end item 3b85f1bf-ea07-4e89-a111-fac941dedf7b -->","subChapters":[{"id":"30d73350-70f0-5c54-b547-e9cdfe1d6b7f","slug":"basis-for-recommendation-647","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field d20c86e2-9fcb-4998-bd1b-2e40a817a00f --><h4>Basis for recommendation</h4><!-- end field d20c86e2-9fcb-4998-bd1b-2e40a817a00f -->","summary":null,"htmlStringContent":"<!-- begin item 6479ac00-70d4-4ca9-9538-88d9799c1f69 --><!-- begin field 87f0be95-63a4-459b-870b-2d6855acbf43 --><p>This recommendation is based on expert opinion in a palliative care guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-cancer-care-pain/references/\">NHS Lothian, 2014b</a>], expert opinion in a textbook: <em>A guide to symptom relief in palliative care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-cancer-care-pain/references/\">Regnard, 2010</a>], a chapter in the <em>ABC of palliative care </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-cancer-care-pain/references/\">Colvin et al, 2006</a>], and the British National Formulary [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-cancer-care-pain/references/\">BNF 72, 2016</a>].</p><ul><li>The recommendation to have a low threshold for giving a proton pump inhibitor is based on expert opinion from reviewers of this CKS topic, who suggested that most people with increased intracranial pressure will have risk factors for gastrointestinal bleeding as well as corticosteroid treatment.</li></ul><!-- end field 87f0be95-63a4-459b-870b-2d6855acbf43 --><!-- end item 6479ac00-70d4-4ca9-9538-88d9799c1f69 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}